Published in J Clin Invest on July 01, 1979
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
Glutamate is a positive autocrine signal for glucagon release. Cell Metab (2008) 2.01
Retracted Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion. J Clin Invest (1986) 1.45
Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest (1987) 1.44
Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes. Pediatr Diabetes (2007) 1.38
Neurobiology of food intake in health and disease. Nat Rev Neurosci (2014) 1.37
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology (2011) 1.32
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest (1984) 1.21
The biochemistry of diabetes. Biochem J (1988) 1.14
Hormonal and metabolic response to hypoglycaemia in small for gestational age infants. Arch Dis Child (1993) 1.12
Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci (2010) 1.10
Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. J Clin Invest (1983) 1.08
Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. J Clin Invest (1982) 0.99
Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects. J Clin Invest (1983) 0.98
Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism. PLoS Comput Biol (2012) 0.96
Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes. J Clin Invest (1986) 0.95
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest (1984) 0.95
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest (1992) 0.95
Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia. West J Med (1984) 0.93
Greater systemic lipolysis in women compared with men during moderate-dose infusion of epinephrine and/or norepinephrine. J Appl Physiol (1985) (2009) 0.93
Glucose counterregulatory responses to hypoglycemia. Pediatr Endocrinol Rev (2011) 0.91
Quantification in vivo of the effects of insulin on glucose utilization in individual tissues of warm- and cold-acclimated rats. Biochem J (1986) 0.89
Role of hepatic autoregulation in defense against hypoglycemia in humans. J Clin Invest (1985) 0.86
Direct muscarinic cholinergic inhibition of hepatic glucose production in humans. J Clin Invest (1988) 0.85
Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man. J Clin Invest (1984) 0.84
Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon. J Diabetes Sci Technol (2014) 0.84
Hypoglycemias. West J Med (1991) 0.82
Glucagon orchestrates stress-induced hyperglycaemia. Diabetes Obes Metab (2016) 0.82
Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms. Diabetes Metab Syndr Obes (2009) 0.81
The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes. Diabetes Technol Ther (2011) 0.81
The effect of genetically engineered glucagon on glucose recovery after hypoglycaemia in man. Br J Clin Pharmacol (1992) 0.80
Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production. J Clin Invest (1985) 0.80
Effects of alpha and beta adrenergic blockade on hepatic glucose balance before and after oral glucose. Role of insulin and glucagon. J Clin Invest (1986) 0.80
Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin. J Clin Invest (1983) 0.80
Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats. Diabetes (2013) 0.79
Adrenergic control of lipolysis in women compared with men. J Appl Physiol (1985) (2014) 0.78
β2-Adrenergic receptor agonist administration promotes counter-regulatory responses and recovery from hypoglycaemia in rats. Diabetologia (2013) 0.78
Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker. Br Heart J (1983) 0.78
Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man. J Clin Pathol (1987) 0.77
Effect of antecedent moderate-intensity exercise on the glycemia-increasing effect of a 30-sec maximal sprint: a sex comparison. Physiol Rep (2015) 0.77
Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation. J Clin Invest (1987) 0.77
Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome). Diabetes Care (2015) 0.77
Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis. J Clin Invest (2016) 0.76
Glutamate Cysteine Ligase-Modulatory Subunit Knockout Mouse Shows Normal Insulin Sensitivity but Reduced Liver Glycogen Storage. Front Physiol (2016) 0.75
Glucagon is absorbed from the rectum but does not hasten recovery from hypoglycaemia in patients with type 1 diabetes. Br J Clin Pharmacol (2008) 0.75
Postprandial mesenteric blood flow. Gut (1991) 0.75
alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice. Br J Pharmacol (2008) 0.75
Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction. Neth Heart J (2005) 0.75
Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia. J Clin Invest (1985) 0.75
Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab (1967) 7.21
Hypoglycemia: a potent stimulus to secretion of growth hormone. Science (1963) 4.58
The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest (1966) 2.92
The control of glycogen metabolism in the liver. Annu Rev Biochem (1976) 2.85
ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE. Recent Prog Horm Res (1963) 2.26
Neural control of the endocrine pancreas. Physiol Rev (1974) 2.21
Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia. Lancet (1966) 2.15
Tissue effects of glucocorticoids. Am J Med (1972) 2.11
Effect of insulin on utilization and production of circulating glucose. Am J Physiol (1957) 2.06
Studies on the role of adenosine 3',5'-monophosphate in the hepatic actions of glucagon and catecholamines. J Biol Chem (1971) 1.85
The hormonal control of hepatic gluconeogenesis. Recent Prog Horm Res (1970) 1.78
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest (1976) 1.63
The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf. J Physiol (1974) 1.58
Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol (1979) 1.53
Effects of insulin after adrenalectomy. Lancet (1956) 1.48
Measurement and validation of nonsteady turnover rates with applications to the inulin and glucose systems. Fed Proc (1974) 1.48
Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. J Clin Endocrinol Metab (1974) 1.37
Plasma catecholamines and blood substrate concentrations: studies in insulin induced hypoglycaemia and after adrenaline infusions. Eur J Clin Invest (1975) 1.33
Adrenergic modulation of basal insulin secretion in man. Diabetes (1973) 1.29
The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. J Clin Invest (1974) 1.29
Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion. Diabetes (1976) 1.24
Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis. J Clin Invest (1975) 1.23
Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes (1974) 1.23
Characterization of the glucagon response to hypoglycemia in man. J Clin Endocrinol Metab (1974) 1.20
Effect of glucagon: insulin ratios on hepatic metabolism. Diabetes (1974) 1.19
THE ACUTE EFFECT OF HYDROCORTISONE ON HEPATIC GLUCOSE OUTPUT AND PERIPHERAL GLUCOSE UTILIZATION. J Clin Invest (1964) 1.18
Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology (1978) 1.18
Comparison of the hyperglycaemic and glycogenolytic responses to catecholamines with those to stimulation of the hepatic sympathetic innervation in the dog. J Physiol (1972) 1.16
Metabolic response to human growth hormone during prolonged starvation. J Clin Invest (1971) 1.01
Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade. Am J Physiol (1979) 0.99
Glucagon response to hypoglycemia in sympathectomized man. J Clin Invest (1976) 0.98
Assessment of hypothalamic pituitary function in endocrine disease. J Clin Pathol (1966) 0.97
Effects of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver. Am J Physiol (1975) 0.97
The effect of phenoxybenzamine and propranolol and their combination on the restoration of glucose homeostasis after insulin induced hypoglycemia. Arch Int Pharmacodyn Ther (1969) 0.96
Pancreatic glucagon response to an ordinary meal. Scand J Gastroenterol (1975) 0.93
Neural control of counter-regulatory events during glucopenia in man. J Clin Invest (1973) 0.90
Studies on the pathogenesis of diabetes in acromegaly. Acta Endocrinol (Copenh) (1967) 0.89
Effects of insulin and growth hormone on the flux rates of plasma glucose and plasma free fatty acids in man. J Clin Endocrinol Metab (1970) 0.89
Autoregulation of glucose metabolism in the isolated perfused rat liver. Proc Soc Exp Biol Med (1967) 0.88
A survey of growth hormone secretion and action. Metabolism (1973) 0.87
Effect of insulin induced hypoglycaemia on the blood levels of catecholamines, glucagon, growth hormone, cortisol, C-peptide and proinsulin before and during medication with the cardioselective beta-receptor blocking agent metoprolol in man. Acta Endocrinol (Copenh) (1978) 0.85
The role of cortisol and growth hormone in the counter-regulation of insulin-induced hypoglycemia. Horm Metab Res (1975) 0.84
Glucoregulatory response to insulin-induced hypoglycemia in Laennec's cirrhosis. J Clin Endocrinol Metab (1978) 0.82
Glucagon responses to hypoglycemia in adrenalectomized man. Metabolism (1976) 0.80
Glucose delivery--a clarification of its role in regulating glucose uptake in rat skeletal muscle. Life Sci (1977) 0.80
The effect of somatostatin on plasma noradrenaline and plasma adrenaline concentrations during exercise and hypoglycemia. Metabolism (1975) 0.80
Mechanism of plasma cyclic AMP response to hypoglycemia in man. Metabolism (1976) 0.79
Direct neural inhibition of insulin secretion in response to systemic hypoglycemia. Am J Physiol (1976) 0.79
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia (2005) 4.61
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med (1995) 4.29
Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol (1981) 3.30
Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science (1973) 2.99
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med (1976) 2.72
Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71
Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest (1989) 2.69
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat (2007) 2.58
Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57
Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest (1980) 2.57
Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med (1980) 2.55
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab (1982) 2.45
Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest (1993) 2.35
Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes (1971) 2.32
Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes (1991) 2.17
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab (2000) 2.15
Perioperative management of surgical patients with diabetes mellitus. Anesthesiology (1991) 2.11
The role of growth hormone in the development of diabetic retinopathy. Diabetes Care (1994) 1.91
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes (1983) 1.86
Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med (1983) 1.83
Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes (1994) 1.81
Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med (1975) 1.80
The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA (1991) 1.74
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia (2007) 1.73
Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes (1981) 1.73
Contribution of liver and skeletal muscle to alanine and lactate metabolism in humans. Am J Physiol (1990) 1.71
Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest (1980) 1.71
Norepinephrine: hormone and neurotransmitter in man. Am J Physiol (1978) 1.66
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest (1976) 1.63
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med (1984) 1.61
Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest (1986) 1.61
Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr (1999) 1.61
Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes (2000) 1.60
Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest (1990) 1.55
Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest (1974) 1.55
Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J (1981) 1.54
Perceived symptoms in the recognition of hypoglycemia. Diabetes Care (1993) 1.53
Isotope-derivative measurements of plasma norepinephrine and epinephrine in man. Diabetes (1976) 1.52
External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med (1985) 1.52
Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol (1993) 1.52
Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab (1980) 1.50
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med (1985) 1.47
Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest (1987) 1.47
Retracted Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion. J Clin Invest (1986) 1.45
Measurements of glucose control. Diabetes Care (1987) 1.45
Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest (1987) 1.44
Assessment of the postprandial pattern of glucose metabolism in nondiabetic subjects and patients with non-insulin-dependent diabetes mellitus using a simultaneous infusion of [2(3)H] and [3(3)H] glucose. Metabolism (1989) 1.42
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes (1990) 1.41
Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes (1982) 1.39
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. J Clin Endocrinol Metab (1974) 1.37
Glucose counterregulation in man. Diabetes (1981) 1.36
Production of insulin resistance by hyperinsulinaemia in man. Diabetologia (1985) 1.36
Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes (1981) 1.35
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab (1973) 1.34
Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. J Clin Invest (1984) 1.34
Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab (2001) 1.33
Extrapancreatic effects of GIP and GLP-1. Horm Metab Res (2005) 1.32
Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes (1986) 1.31
Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol (1999) 1.31
Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number. J Clin Invest (1980) 1.29
Plasma catecholamines in diabetes. The syndromes of hypoadrenergic and hyperadrenergic postural hypotension. Am J Med (1978) 1.29
Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism (1980) 1.28
Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest (1996) 1.28
Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab (1981) 1.28
Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med (1980) 1.28
Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism (1988) 1.27
Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care (1998) 1.25
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest (1990) 1.25
Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med (1988) 1.25
Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion. Diabetes (1976) 1.24
Somatostatin. Physiology and clinical applications. Med Clin North Am (1978) 1.24
Effect of stepped hypoglycemia on regional cerebral blood flow response to physiological brain activation. Am J Physiol (1996) 1.24
Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acid. J Clin Invest (1981) 1.24
Documented hypoglycemia for 23 years in a patient with insulinoma. JAMA (1978) 1.23
Regulation of pancreatic insulin and glucagon secretion. Annu Rev Physiol (1976) 1.23
High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension (1994) 1.22
Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis. Diabetes (1974) 1.21
Characterization of the glucagon response to hypoglycemia in man. J Clin Endocrinol Metab (1974) 1.20
Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects. Diabetologia (1983) 1.20
Glossopharyngeal neuralgia with syncope secondary to tumor. Treatment and pathophysiology. Am J Med (1981) 1.20
Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes (1988) 1.16